Germany’s BioNTech Settles With US Agency, UPenn Over COVID Vaccine Royalties

Share!

Insurance Journal - Dec 27, 2024

BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania over the payment of royalties related to its COVID-19 vaccine, the company said in filings. The German company, which partners …...

Read Full Article

Recommended Articles

Texas Summer Camp Faces Scrutiny Over Failure to Report Deaths

Posted: Apr 16, 2026

The medical officer for the Texas summer camp where 27 girls were killed in a flood last year testif...

Trucordia Buys Connecticut’s Paradiso Insurance Services

Posted: Apr 16, 2026

Utah-based insurance broker Trucordia reports it has acquired the Paradiso Financial and Insurance S...

Inszone Acquires Kansas’ Insurance Resources Group

Posted: Apr 16, 2026

Inszone Insurance Services announced the acquisition of Insurance Resources Group, Inc. Located in O...